SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Trust Co. of Vermont

Trust Co. of Vermont cut its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 12.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,683 shares of the exchange traded fund’s stock after selling 375 shares during the quarter. Trust Co. of Vermont’s holdings in SPDR S&P Biotech ETF were worth $242,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after buying an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd bought a new position in SPDR S&P Biotech ETF in the third quarter worth about $141,284,000. Affinity Asset Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 105.4% in the second quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock valued at $3,481,000 after acquiring an additional 737,550 shares during the period. Assetmark Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 72,653.0% during the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after purchasing an additional 588,489 shares during the last quarter. Finally, Sivik Global Healthcare LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $29,640,000.

SPDR S&P Biotech ETF Trading Up 0.1 %

Shares of NYSEARCA XBI opened at $87.97 on Monday. The company has a market cap of $6.71 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock’s 50 day simple moving average is $94.09 and its 200 day simple moving average is $96.98. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.